Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834; NDC 51862-295-10.
Published April 11, 2018 · Recall initiated: March 21, 2018
Summary
FDA records drug Class III recall D-0616-2018, published April 11, 2018 and initiated March 21, 2018. Recalling firm: Mayne Pharma Inc; Status: Terminated; Reported quantity: 3312 cans; Lot: Lot: MBEB, Exp. 01/31/2019. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug: High out of specification results for tazarotene assay at the 9-month stability time point.
What to do
Voluntary: Firm initiated · Letter
Get an email if FABIOR has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FABIOR
- Manufacturer
- Mayne Pharma Inc
- Distributor
- Nationwide in the USA
- Lot
- Lot: MBEB, Exp. 01/31/2019
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAbuPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 60 count bottles, Rx Only, Manufactured for: CiplaApril 11, 2018
- FDAbuPROPion HCl Extended-Release Tablets, USP (SR), 150 mg ,a) 60 count (NDC 69097-878-03) and b) 100 count (NDCApril 11, 2018
- FDACoconut Smiles - Retail: International Harvest Brand Organic Go Smile! Dried Coconut Raw, in a 9 oz.April 11, 2018
- FDAIMRIS ORT300, Removable Operating Room Table, Part Numbers: (a) 114093-000 (b) 114093-600April 4, 2018
- FDAF-T3SYSTEM, T3 (Trumpf Table Top) System The device is a surgical table accessory system used to allow proneApril 4, 2018
- FDAAltivate Anatomic(TM) INSTRUMENTATION, PEGGED GLENOID TRIAL, SIZE 54mm, REF 804-07-540 Product Usage: TheApril 4, 2018
Questions about this recall
Was Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834; NDC 51862-295-10. recalled?
Yes. FDA published recall D-0616-2018 on April 11, 2018. Reported hazard: Superpotent Drug: High out of specification results for tazarotene assay at the 9-month stability time point.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FABIOR.